Piramal Pharma Limited (PPL) has announced an upcoming conference call for investors and analysts to discuss its Q3 and 9M FY2026 financial results.

The call is scheduled to take place on January 29, 2026, from 9:30 AM to 10:15 AM IST. Participants can join the call using the provided dial-in details for various international locations including India, USA, UK, Singapore, and Hong Kong. An option for express joining via Diamond Pass is also available for prior registration to minimize wait times.

Piramal Pharma Solutions offers a portfolio of products and services through its global development and manufacturing facilities. The company's businesses include Piramal Pharma Solutions (PPS), Piramal Critical Care (PCC), and Piramal Consumer Healthcare. PPL also has an associate company in ophthalmology and a strategic investment in Yapan Bio Private Limited.